Application of gut microbiome in the diagnosis and treatment of tumor

doi:10.3760/cma.j.cn371439-20201019-00084

Abstract

Abstract:

Gut microbiome is closely related to human health. Changes in intestinal microbial composition promote the development of tumors. Specific intestinal microorganisms and their metabolites regulate host physiological functions and tumor microenvironment, significantly affecting the anti-cancer treatment response and its adverse events. Strategies targeting gut microbiome have shown promising prospects in diagnosis and treatment of cancer.

Key words: Gut microbiome, Tumor microenvironment, Immunotherapy

An Jianghong, Qian Shen, Luo Pu, Tan Xiaohua. Application of gut microbiome in the diagnosis and treatment of tumor[J]. Journal of International Oncology, 2021, 48(7): 436-440.

References 30

[1]	Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy[J]. Nat Rev Cancer, 2017, 17(5):271-285. DOI: 10.1038/nrc.2017.13. doi: 10.1038/nrc.2017.13
[2]	Makki K, Deehan EC, Walter J, et al. The impact of dietary fiber on gut microbiota in host health and disease[J]. Cell Host Microbe, 2018, 23(6):705-715. DOI: 10.1016/j.chom.2018.05.012. doi: 10.1016/j.chom.2018.05.012
[3]	Huybrechts I, Zouiouich S, Loobuyck A, et al. The human micro-biome in relation to cancer risk: a systematic review of epidemiologic studies[J]. Cancer Epidemiol Biomarkers Prev, 2020, 29(10):1856-1868. DOI: 10.1158/1055-9965.epi-20-0288. doi: 10.1158/1055-9965.EPI-20-0288
[4]	Nejman D, Livyatan I, Fuks G, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria[J]. Science, 2020, 368(6494):973-980. DOI: 10.1126/science.aay9189. doi: 10.1126/science.aay9189
[5]	Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, et al. Mutational signature in colorectal cancer caused by genotoxic pks⁺ E. coli[J]. Nature, 2020, 580(7802):269-273. DOI: 10.1038/s41586-020-2080-8. doi: 10.1038/s41586-020-2080-8
[6]	Dejea CM, Fathi P, Craig JM, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria[J]. Science, 2018, 359(6375):592-597. DOI: 10.1126/science.aah3648. doi: 10.1126/science.aah3648
[7]	Coutzac C, Jouniaux JM, Paci A, et al. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer[J]. Nat Commun, 2020, 11(1):2168. DOI: 10.1038/s41467-020-16079-x. doi: 10.1038/s41467-020-16079-x pmid: 32358520
[8]	Yu AI, Zhao L, Eaton KA, et al. Gut microbiota modulate CD8 T cell responses to influence colitis-associated tumorigenesis[J]. Cell Rep, 2020, 31(1):107471. DOI: 10.1016/j.celrep.2020.03.035. doi: 10.1016/j.celrep.2020.03.035
[9]	Gopalakrishnan V, Spencer CN, Nezi L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients[J]. Science, 2018, 359(6371):97-103. DOI: 10.1126/science.aan4236. doi: 10.1126/science.aan4236 pmid: 29097493
[10]	肖俊娟, 毕振旺, 李岩. 肠道微生态与肿瘤免疫调节的相关研究[J]. 国际肿瘤学杂志, 2017, 44(1):34-37. DOI: 10.3760/cma.j.issn.1673-422x.2017.01.009.
[11]	Riquelme E, Zhang Y, Zhang L, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes[J]. Cell, 2019, 178(4):795-806, e12. DOI: 10.1016/j.cell.2019.07.008. doi: S0092-8674(19)30773-1 pmid: 31398337
[12]	Pushalkar S, Hundeyin M, Daley D, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression[J]. Cancer Discov, 2018, 8(4):403-416. DOI: 10.1158/2159-8290.cd-17-1134. doi: 10.1158/2159-8290.CD-17-1134 pmid: 29567829
[13]	Ferrie S, Webster A, Wu B, et al. Gastrointestinal surgery and the gut microbiome: a systematic literature review[J]. Eur J Clin Nutr, 2020, In press. DOI: 10.1038/s41430-020-0681-9.
[14]	van Praagh JB, de Goffau MC, Bakker IS, et al. Mucus microbiome of anastomotic tissue during surgery has predictive value for colorectal anastomotic leakage[J]. Ann Surg, 2019, 269(5):911-916. DOI: 10.1097/sla.0000000000002651. doi: 10.1097/SLA.0000000000002651
[15]	Gaines S, van Praagh JB, Williamson AJ, et al. Western diet promotes intestinal colonization by collagenolytic microbes and promotes tumor formation after colorectal surgery[J]. Gastroenterology, 2020, 158(4):958-970, e2. DOI: 10.1053/j.gastro.2019.10.020. doi: S0016-5085(19)41471-6 pmid: 31655031
[16]	Darbandi A, Mirshekar M, Shariati A, et al. The effects of probio-tics on reducing the colorectal cancer surgery complications: a perio-dic review during 2007—2017[J]. Clin Nutr, 2020, 39(8):2358-2367. DOI: 10.1016/j.clnu.2019.11.008. doi: S0261-5614(19)33135-8 pmid: 31831184
[17]	Panebianco C, Andriulli A, Pazienza V. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies[J]. Microbiome, 2018, 6(1):92. DOI: 10.1186/s40168-018-0483-7. doi: 10.1186/s40168-018-0483-7 pmid: 29789015
[18]	Loman BR, Jordan KR, Haynes B, et al. Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice[J]. Sci Rep, 2019, 9(1):16490. DOI: 10.1038/s41598-019-52893-0. doi: 10.1038/s41598-019-52893-0 pmid: 31712703
[19]	Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy[J]. Cell, 2017, 170(3):548-563, e16. DOI: 10.1016/j.cell.2017.07.008. doi: 10.1016/j.cell.2017.07.008
[20]	Gerassy-Vainberg S, Blatt A, Danin-Poleg Y, et al. Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction[J]. Gut, 2018, 67(1):97-107. DOI: 10.1136/gutjnl-2017-313789. doi: 10.1136/gutjnl-2017-313789 pmid: 28438965
[21]	Cui M, Xiao H, Li Y, et al. Faecal microbiota transplantation protects against radiation-induced toxicity[J]. EMBO Mol Med, 2017, 9(4):448-461. DOI: 10.15252/emmm.201606932. doi: 10.15252/emmm.201606932
[22]	Guo H, Chou WC, Lai Y, et al. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites[J]. Science, 2020, 370(6516):eaay9097. DOI: 10.1126/science.aay9097. doi: 10.1126/science.aay9097
[23]	Liu MM, Li ST, Shu Y, et al. Probiotics for prevention of radiation-induced diarrhea: a meta-analysis of randomized controlled trials[J]. PLoS One, 2017, 12(6):e0178870. DOI: 10.1371/journal.pone.0178870. doi: 10.1371/journal.pone.0178870
[24]	Chalabi M, Cardona A, Nagarkar DR, et al. Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials[J]. Ann Oncol, 2020, 31(4):525-531. DOI: 10.1016/j.annonc.2020.01.006. doi: S0923-7534(20)35927-5 pmid: 32115349
[25]	Wang Y, Wiesnoski DH, Helmink BA, et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis[J]. Nat Med, 2018, 24(12):1804-1808. DOI: 10.1038/s41591-018-0238-9. doi: 10.1038/s41591-018-0238-9
[26]	Chaput N, Lepage P, Coutzac C, et al. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab[J]. Ann Oncol, 2017, 28(6):1368-1379. DOI: 10.1093/annonc/mdx108. doi: 10.1093/annonc/mdx108 pmid: 28368458
[27]	Zheng DW, Chen Y, Li ZH, et al. Optically-controlled bacterial metabolite for cancer therapy[J]. Nat Commun, 2018, 9(1):1680. DOI: 10.1038/s41467-018-03233-9. doi: 10.1038/s41467-018-03233-9
[28]	Mager LF, Burkhard R, Pett N, et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy[J]. Science, 2020, 369(6510):1481-1489. DOI: 10.1126/science.abc3421. doi: 10.1126/science.abc3421
[29]	Gregory AC, Zablocki O, Zayed AA, et al. The Gut Virome Database reveals age-dependent patterns of virome diversity in the human gut[J]. Cell Host Microbe, 2020, 28(5):724-740, e8. DOI: 10.1016/j.chom.2020.08.003. doi: 10.1016/j.chom.2020.08.003
[30]	Lim B, Zimmermann M, Barry NA, et al. Engineered regulatory systems modulate gene expression of human commensals in the gut[J]. Cell, 2017, 169(3):547-558, e15. DOI: 10.1016/j.cell.2017.03.045. doi: 10.1016/j.cell.2017.03.045